A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection
Clinical trial NCT04342663 · COMPLETED
Trial details
- NCT number
- NCT04342663
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-10
- Primary completion
- 2020-08-20
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.